Ostéonécrose des maxillaires chez des patients traités par bisphosphonates
- 30 September 2005
- journal article
- research article
- Published by Elsevier in La Presse Médicale
- Vol. 34 (15) , 1073-1077
- https://doi.org/10.1016/s0755-4982(05)84119-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- From Molds and Macrophages to Mevalonate: A Decade of Progress in Understanding the Molecular Mode of Action of BisphosphonatesCalcified Tissue International, 2004
- The role of bisphosphonates in breast and prostate cancers.Endocrine-Related Cancer, 2004
- Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 casesJournal of Oral and Maxillofacial Surgery, 2004
- SAPHO syndrome treated with pamidronate: an open-label study of 10 patientsRheumatology, 2004
- Bisphosphanates and Oral Cavity Avascular Bone NecrosisJournal of Clinical Oncology, 2003
- Zoledronate Sensitizes Endothelial Cells to Tumor Necrosis Factor-induced Programmed Cell DeathPublished by Elsevier ,2003
- Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemicJournal of Oral and Maxillofacial Surgery, 2003
- Alendronate in the treatment of avascular necrosis of the hipRheumatology, 2002
- Bisphosphonates induce apoptosis in human breast cancer cell linesBritish Journal of Cancer, 2000
- Bisphosphonates: from the laboratory to the clinic and back againBone, 1999